MARKET

XBI

XBI

State Street® SPDR® S&P® Biotech ETF
NYSEARCA
122.62
-3.76
-2.98%
Closed 19:48 03/12 EDT
OPEN
124.75
PREV CLOSE
126.38
HIGH
124.85
LOW
121.81
VOLUME
11.52M
TURNOVER
344.82M
52 WEEK HIGH
132.09
52 WEEK LOW
66.42
TOTAL ASSET
8.10B
YTD YIELD
41.14%
1D
5D
1M
3M
1Y
5Y
1D
BridgeBio Pharma Eyes First Treatment For Rare Muscle Disorder As Trial Data Shows Early Progress
Benzinga · 23h ago
Trader calls dollar-cost averaging a 'scam,' sparking heated debate
Seeking Alpha · 1d ago
XBI, MRNA, PCVX, ROIV: ETF Outflow Alert
NASDAQ · 3d ago
This biotech’s stock is soaring after a ‘polarizing’ FDA official is stepping down
MarketWatch · 3d ago
Weekly Report: what happened at XBI last week (0302-0306)?
Weekly Report · 4d ago
HQH: Strong Returns Fuel Higher Payout, But Valuation Not As Compelling (Downgrade)
Seeking Alpha · 03/03 22:28
MAHA Is Bringing Chaos to Biotech Investment Beyond Just Vaccines -- Heard on the Street
The Wall Street Journal · 03/03 10:30
AAPL, AA, BKR, and AMGN are among the top stocks for momentum, says Oppenheimer
Seeking Alpha · 03/02 18:04
More
Profile
Fund Name
State Street® SPDR® S&P® Biotech ETF
Inception Date
2006-01-31
Benchmark
S&P 500 TR USD
Advisor Company
SPDR State Street Investment Management
Custodian
State Street Bank & Trust Co
Manager
Michael Feehily, Emiliano Rabinovich, Raymond Donofrio, Karl Schneider